Latest Clinical Trials
A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants Bayer NA
RECRUITING
(Sep 22, 2026)
PHASE1 Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV National Cancer Institute (NCI) NA
RECRUITING
(Sep 10, 2026)
PHASE1 Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation National Cancer Institute (NCI) NA
ACTIVE NOT RECRUITING
(Sep 1, 2026)
PHASE2 Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients Cerus Corporation NA
COMPLETED
(Sep 1, 2026)
PHASE3 Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis University of Florida NA
ACTIVE NOT RECRUITING
(Sep 1, 2026)
PHASE3 Polypill in Acute Coronary Syndrome University of Texas Southwestern Medical Center NA
COMPLETED
(Sep 1, 2026)
PHASE2 APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia University of Pennsylvania NA
RECRUITING
(Sep 1, 2026)
PHASE3 Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT) Capital Medical University NA
RECRUITING
(Sep 1, 2026)
PHASE3 Reduce Opiate Exposure With ACL Surgery Campbell Clinic NA
ENROLLING BY INVITATION
(Sep 1, 2026)
PHASE3 Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG) University of Virginia NA
RECRUITING
(Sep 1, 2026)
PHASE1 Aspirin in Acute Pneumonia in the Elderly: a Multicenter, Double-blind, Randomized, Placebo-controlled Trial. Centre Hospitalier Universitaire Dijon NA
NOT YET RECRUITING
(Sep 1, 2026)
PHASE3 Thrombolysis in Factor Xa-inhibitors Trial Guri Hagberg NA
RECRUITING
(Sep 1, 2026)
PHASE3 A Polypill for Acute Coronary Syndrome University of Texas Southwestern Medical Center NA
RECRUITING
(Sep 1, 2026)
PHASE2 Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage Christian Medical College and Hospital, Ludhiana, India NA
RECRUITING
(Sep 1, 2026)
PHASE3 Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial Montreal Heart Institute NA
RECRUITING
(Sep 1, 2026)
PHASE3 Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke The First Affiliated Hospital of Anhui Medical University NA
NOT YET RECRUITING
(Sep 1, 2026)
PHASE3 The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent First Affiliated Hospital of Fujian Medical University NA
NOT YET RECRUITING
(Sep 1, 2026)
PHASE3 TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study University Hospital, Toulouse NA
NOT YET RECRUITING
(Sep 1, 2026)
PHASE3 Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma National Cancer Institute (NCI) NA
ACTIVE NOT RECRUITING
(Aug 21, 2026)
PHASE1 Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors National Cancer Institute (NCI) NA
COMPLETED
(Aug 6, 2026)
PHASE1 Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy Alliance for Clinical Trials in Oncology NA
TERMINATED
(Aug 1, 2026)
PHASE3 Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma National Cancer Institute (NCI) NA
ACTIVE NOT RECRUITING
(Aug 1, 2026)
PHASE2 Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H) Columbia University NA
COMPLETED
(Aug 1, 2026)
PHASE3 Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects Rhoshan Pharmaceuticals Inc NA
COMPLETED
(Aug 1, 2026)
PHASE1 The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia Yoo-min Kim NA
RECRUITING
(Aug 1, 2026)
PHASE3 Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer Mayo Clinic NA
RECRUITING
(Aug 1, 2026)
PHASE2 Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease Brigham and Women's Hospital NA
ACTIVE NOT RECRUITING
(Aug 1, 2026)
PHASE2 Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer Virginia Commonwealth University NA
RECRUITING
(Aug 1, 2026)
PHASE2 Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS) Population Health Research Institute NA
NOT YET RECRUITING
(Aug 1, 2026)
PHASE3 Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy BreakBio Corp NA
NOT YET RECRUITING
(Aug 1, 2026)
PHASE1, PHASE2 Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy BreakBio Corp NA
NOT YET RECRUITING
(Aug 1, 2026)
PHASE1, PHASE2 APEX-STROKE Adaptive Platform Trial for Stroke Fudan University NA
NOT YET RECRUITING
(Aug 1, 2026)
PHASE3 Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II) Northern California Institute of Research and Education NA
RECRUITING
(Jul 1, 2026)
PHASE3 ACT-GLOBAL Adaptive Platform Trial for Stroke The George Institute NA
RECRUITING
(Jul 1, 2026)
PHASE3 LEARNER- Low dosE AspiRiN prEterm tRial (Angola) Instituto Nacional de Investigacao em Saude, Angola NA
ACTIVE NOT RECRUITING
(Jul 1, 2026)
PHASE1, PHASE2 Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II) Jesper Kjaergaard NA
RECRUITING
(Jul 1, 2026)
PHASE3 Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime) University of Alberta NA
COMPLETED
(Jul 1, 2026)
PHASE2 Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial) Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o. NA
RECRUITING
(Jul 1, 2026)
PHASE3 Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease Children's Hospital of Fudan University NA
NOT YET RECRUITING
(Jul 1, 2026)
PHASE2, PHASE3 Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction Neurodawn Pharmaceutical Co., Ltd. NA
NOT YET RECRUITING
(Jul 1, 2026)
PHASE2, PHASE3 Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk University Hospital, Rouen NA
ACTIVE NOT RECRUITING
(Jun 1, 2026)
PHASE3 Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery Roswell Park Cancer Institute NA
ACTIVE NOT RECRUITING
(Jun 1, 2026)
PHASE2 The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions Marissa Jarosinski NA
TERMINATED
(Jun 1, 2026)
PHASE3 Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis ANRS, Emerging Infectious Diseases NA
RECRUITING
(Jun 1, 2026)
PHASE3 Poly-unsaturated Fats for Improving Nasal Polyps and Asthma Norfolk and Norwich University Hospitals NHS Foundation Trust NA
COMPLETED
(Jun 1, 2026)
PHASE3 The Seven Trial: Exploiting the Unfolded Protein Response HonorHealth Research Institute NA
TERMINATED
(Jun 1, 2026)
PHASE1 The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity University of Calgary NA
RECRUITING
(Jun 1, 2026)
PHASE3 Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke Xiang Luo NA
COMPLETED
(Jun 1, 2026)
PHASE2, PHASE3 CiLostAzol for pReventIon of Recurrent sTroke in Africa Northern California Institute of Research and Education NA
NOT YET RECRUITING
(Jun 1, 2026)
PHASE3 Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects Rhoshan Pharmaceuticals Inc NA
COMPLETED
(Jun 1, 2026)
PHASE1 HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN) Weifang Medical University NA
RECRUITING
(Jun 1, 2026)
PHASE3 Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization Fondation Hôpital Saint-Joseph NA
RECRUITING
(Jun 1, 2026)
PHASE3 Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease Xuanwu Hospital, Beijing NA
NOT YET RECRUITING
(Jun 1, 2026)
PHASE3 Optimizing the Use of Aspirin for the Prevention of Preeclampsia Hospital Universitari Vall d'Hebron Research Institute NA
NOT YET RECRUITING
(Jun 1, 2026)
PHASE3 Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill University Hospital, Montpellier NA
COMPLETED
(May 1, 2026)
PHASE3 T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma National Cancer Institute (NCI) NA
COMPLETED
(May 1, 2026)
PHASE1 A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome M.D. Anderson Cancer Center NA
RECRUITING
(May 1, 2026)
PHASE2 Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome National Cancer Institute (NCI) NA
ACTIVE NOT RECRUITING
(May 1, 2026)
PHASE2 Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology University Hospital, Toulouse NA
RECRUITING
(May 1, 2026)
PHASE3 Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets Centre Hospitalier Universitaire de Saint Etienne NA
RECRUITING
(May 1, 2026)
PHASE3 A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants With Stable Coronary Artery Disease Ribocure Pharmaceuticals AB NA
COMPLETED
(May 1, 2026)
PHASE2 Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE Sichuan Provincial People's Hospital NA
RECRUITING
(May 1, 2026)
PHASE3 Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countries Khalid F Alhabib NA
NOT YET RECRUITING
(May 1, 2026)
PHASE3 Pro-urokinase for Extended-Window Posterior Circulation Stroke The First Affiliated Hospital of Zhengzhou University NA
NOT YET RECRUITING
(May 1, 2026)
PHASE3 Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma National Cancer Institute (NCI) NA
ACTIVE NOT RECRUITING
(Apr 1, 2026)
PHASE3 Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Alliance for Clinical Trials in Oncology NA
COMPLETED
(Apr 1, 2026)
PHASE3 Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease Children's Hospital of Fudan University NA
COMPLETED
(Apr 1, 2026)
PHASE3 Randomised Evaluation of COVID-19 Therapy University of Oxford NA
RECRUITING
(Apr 1, 2026)
PHASE3 AERIAL Trial: Antiplatelet Therapy in Heart Transplantation Ottawa Heart Institute Research Corporation NA
RECRUITING
(Apr 1, 2026)
PHASE3 Mechanisms of Dupilumab in AERD Scripps Clinic NA
COMPLETED
(Apr 1, 2026)
PHASE2 Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale Chinese Academy of Medical Sciences, Fuwai Hospital NA
COMPLETED
(Apr 1, 2026)
PHASE2 Anti-Platelets in Chronic Obstructive Pulmonary Disease Brigham and Women's Hospital NA
COMPLETED
(Apr 1, 2026)
PHASE2 Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke Kafrelsheikh University NA
RECRUITING
(Apr 1, 2026)
PHASE3 Pomalidomide as an Immune-enhancing Agent for the Control of HIV University of Aarhus NA
ACTIVE NOT RECRUITING
(Apr 1, 2026)
PHASE1, PHASE2 Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial The George Washington University Biostatistics Center NA
RECRUITING
(Apr 1, 2026)
PHASE3 A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease Sirius Therapeutics Co., Ltd. NA
RECRUITING
(Apr 1, 2026)
PHASE2 Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial Curtin University NA
NOT YET RECRUITING
(Apr 1, 2026)
PHASE3 Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch The First Affiliated Hospital of Zhengzhou University NA
NOT YET RECRUITING
(Apr 1, 2026)
PHASE3 Spatiotemporal Evolution of Traditional Chinese Medicine Mechanisms in Acute Ischemic Stroke Treated With Dengzhan Xixin and Dengzhan Shengmai Guangdong Provincial Hospital of Traditional Chinese Medicine NA
NOT YET RECRUITING
(Apr 1, 2026)
PHASE2, PHASE3 Aspirin to Target Arterial Events in Chronic Kidney Disease University of Southampton NA
TERMINATED
(Mar 1, 2026)
PHASE3 Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND Beijing Tiantan Hospital NA
RECRUITING
(Mar 1, 2026)
PHASE3 Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy Chinese University of Hong Kong NA
RECRUITING
(Mar 1, 2026)
PHASE3 Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves Rawalpindi Institute of Cardiology NA
ENROLLING BY INVITATION
(Mar 1, 2026)
PHASE3 Counterpain PXM Versus Diclofenac Versus Piroxicam Taisho Pharmaceutical Indonesia NA
COMPLETED
(Mar 1, 2026)
PHASE3 
